Provider Discussion, Education, and Question-Asking about Control Medications during Pediatric Asthma Visits.

Provider Discussion, Education, and Question-Asking about Control Medications during Pediatric Asthma Visits.
复制标题

DOI:
10.1155/2011/212160
复制
发表时间:
2011
影响因子:
2.1
通讯作者:
Gillette C
Gillette C
中科院分区:
其他
文献类型:
--
作者:
Sleath B;Carpenter DM;Ayala GX;Williams D;Davis S;Tudor G;Yeatts K;Gillette C

文献摘要

被引文献

相似文献

背景资料。很少有研究探讨在儿童哮喘就诊期间,提供者如何就控制药物进行沟通。目标。这项研究的目的是:(A)描述提供者讨论、教育和询问儿童及其照顾者关于对照药物的问题的程度,以及(B)检查儿童、照顾者和提供者的特征如何与提供者在儿童哮喘就诊期间关于对照药物的沟通相关联。方法:研究方法。8至16岁患有轻度、中度或重度持续性哮喘的儿童及其照顾者被招募到北卡罗来纳州非城市地区的五个儿科诊所。在对医疗访问进行录音后,照顾者完成了问卷调查,并对儿童进行了采访。使用广义估计方程对数据进行分析。结果。在61%的访问中,提供者对家庭进行了关于控制药物的教育,在67%的访问中,他们询问了关于控制药物的问题。如果儿童正在服用对照药物,如果儿童患有中度到重度的持续性哮喘,如果儿童正在进行与哮喘相关的访问,那么提供者讨论控制药物的可能性要大得多。结论。提供者需要教育家庭,并向他们询问更多关于副作用和控制药物效果如何的问题。
Background. Few studies have explored how providers communicate about control medications during pediatric asthma visits. Objectives. The purpose of this study was to: (a) describe the extent to which providers discuss, educate, and ask children and their caregivers questions about control medications and (b) examine how child, caregiver, and provider characteristics are associated with provider communication about control medications during pediatric asthma visits. Methods. Children ages 8 through 16 with mild, moderate, or severe persistent asthma and their caregivers were recruited at five pediatric practices in nonurban areas of North Carolina. After audio-tape recording medical visits, caregivers completed questionnaires and children were interviewed. Generalized estimating equations were used to analyze the data. Results. Providers educated families about control medications during 61% of the visits, and they asked questions about control medications during 67% of visits. Providers were significantly more likely to discuss control medications if a child was taking a control medication, if the child had moderate to severe persistent asthma, and if the child was present for an asthma-related visit. Conclusion. Providers need to educate and ask more questions of families about side effects and how well control medications are working.